May
10
TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial
Studying the delivery of SD-101 via pressure-enabled drug delivery in adults with hepatocellular carcinoma...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.